Written by Stuart Stevens | Friday, 27 April 2007| There are 0 comments
The new female sexual dysfunction drug called Intrinsa which is now on the market in the UK will be extremely useful for women to have undergone a hysterectomy and are suffering from the effects of a reduced libido and loss of interest in sex. One of the biggest problems that can affect a relationship that has been healthy sexually for many years is when one of the partners undergoes surgery in an area that can affect sexual function.

For men this tends to be if they suffer from prostate problems such as prostate cancer which is known to greatly increase the likleyhood of suffering from erectile dysfunction, and for women the biggest cause of lack of enjoyment of sex is after they have had their womb removed in the hysterectomy operation.
At Ukmedix News we have learned that the best form of treatment for sexual problems his communication. Without honest and open communication channels between the two individuals involved in a sexual relationship the chances of curing the sexual dysfunction in a man or in a woman are much reduced.
The new sex drug for women, Intrinsa, works by releasing small amounts of testosterone into the bloodstream of a woman and it has been shown to significantly enhance the interest that women show in sex. It is unlike Viagra in that it does not work instantly but is administered in the form of a patch that slowly releases testosterone into the bloodstream over a long period.
Female sexual dysfunction is notoriously complicated to cure unlike male sexual dysfunction which is normally just a blood flow problem. Intrinsa is the first medication to come on the market to help women with sexual problems and it is not going to be the last as the potential financial gains for a drug that cures all women of sexual problems are huge.
